Wells Fargo downgraded Oscar Health from Overweight to Equal Weight and set a new price target of $16.00 from $20.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/24/2025 | Outperform → Mkt Perform | Raymond James | |
| 3/13/2025 | $20.00 → $16.00 | Overweight → Equal Weight | Wells Fargo |
| 12/10/2024 | $12.00 | Underperform | Jefferies |
| 11/6/2024 | $21.00 → $13.50 | Neutral → Underperform | BofA Securities |
| 10/7/2024 | $23.00 | Neutral | UBS |
| 6/26/2024 | $25.00 | Overweight | Piper Sandler |
| 5/30/2024 | $28.00 | Outperform | Robert W. Baird |
| 5/30/2024 | $25.00 → $21.00 | Buy → Neutral | BofA Securities |